VIP vs Orexin A: What’s the Difference?
The main difference between VIP and Orexin A is mechanism: VIP is studied for anti-inflammatory and cirs research — Activates VPAC1 and VPAC2 receptors; modulates cytokine balance toward Th2/regulatory, supports vasodilation, and influences circadian rhythm. Orexin A is studied for wakefulness and arousal neuropeptide research — Activates OX1R and OX2R receptors in arousal centers (locus coeruleus, raphe, TMN), driving wakefulness, appetite, and reward.
Vasoactive intestinal peptide vs wake-promoting orexin.
Key differences between VIP and Orexin A
- •Mechanism: VIP — Activates VPAC1 and VPAC2 receptors; modulates cytokine balance toward Th2/regulatory, supports vasodilation, and influences circadian rhythm. Orexin A — Activates OX1R and OX2R receptors in arousal centers (locus coeruleus, raphe, TMN), driving wakefulness, appetite, and reward.
- •Primary research focus: VIP is studied for anti-inflammatory and cirs research; Orexin A is studied for wakefulness and arousal neuropeptide research.
- •Overlap: the two compounds share brain & cognitive support.
- •Discussion context: VIP is most often discussed alongside anti-inflammatory and cirs research, while Orexin A centres on wakefulness and arousal neuropeptide research.
| Attribute | VIP Vasoactive Intestinal Peptide | Orexin A Hypocretin-1 |
|---|---|---|
| Category | Immune System & Inflammation | Sleep & Stress Support |
| Best known for | Anti-inflammatory and CIRS research | Wakefulness and arousal neuropeptide research |
| In plain English | It's an anti-inflammatory signal the body makes itself; used in research for hard-to-treat inflammatory states. | It's the body's natural 'stay awake and alert' chemical — narcolepsy is essentially orexin deficiency. |
| How it works | Activates VPAC1 and VPAC2 receptors; modulates cytokine balance toward Th2/regulatory, supports vasodilation, and influences circadian rhythm. | Activates OX1R and OX2R receptors in arousal centers (locus coeruleus, raphe, TMN), driving wakefulness, appetite, and reward. |
| Researchers study | CIRS (chronic inflammatory response syndrome), pulmonary hypertension, and autoimmune research. | Narcolepsy, cognition, and metabolic regulation. |
| Internet discussion | Heavily discussed in Shoemaker-protocol and mold-illness communities. | Discussed in nootropic and wakefulness research circles. |
VIP
Anti-inflammatory and CIRS research
It's an anti-inflammatory signal the body makes itself; used in research for hard-to-treat inflammatory states.
Activates VPAC1 and VPAC2 receptors; modulates cytokine balance toward Th2/regulatory, supports vasodilation, and influences circadian rhythm.
CIRS (chronic inflammatory response syndrome), pulmonary hypertension, and autoimmune research.
Heavily discussed in Shoemaker-protocol and mold-illness communities.
VIP is an endogenous neuropeptide researched for anti-inflammatory effects, vasodilation, and CIRS protocols.
Orexin A
Wakefulness and arousal neuropeptide research
It's the body's natural 'stay awake and alert' chemical — narcolepsy is essentially orexin deficiency.
Activates OX1R and OX2R receptors in arousal centers (locus coeruleus, raphe, TMN), driving wakefulness, appetite, and reward.
Narcolepsy, cognition, and metabolic regulation.
Discussed in nootropic and wakefulness research circles.
Orexin A is a hypothalamic neuropeptide researched for wakefulness, arousal, and appetite regulation.